Your browser doesn't support javascript.
loading
Neutralising activity and antibody titre in 10 patients with breakthrough infections of the SARS-CoV-2 Omicron variant in Japan.
Okumura, Nobumasa; Tsuzuki, Shinya; Saito, Sho; Hattori, Shin-Ichiro; Takeuchi, Junko S; Saito, Tomoya; Ujiie, Mugen; Hojo, Masayuki; Iwamoto, Noriko; Sugiura, Wataru; Mitsuya, Hiroaki; Ohmagari, Norio.
Afiliação
  • Okumura N; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Tsuzuki S; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan; AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan; Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
  • Saito S; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: ssaito@hosp.ncgm.go.jp.
  • Hattori SI; Department of Refractory Viral Infections, National Center for Global Health and Medicine Research Institute, Tokyo, Japan.
  • Takeuchi JS; Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
  • Saito T; Center for Emergency Preparedness and Response, National Institute of Infectious Diseases, Tokyo, Japan.
  • Ujiie M; Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan.
  • Hojo M; Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan.
  • Iwamoto N; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Sugiura W; Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
  • Mitsuya H; Department of Refractory Viral Infections, National Center for Global Health and Medicine Research Institute, Tokyo, Japan.
  • Ohmagari N; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan; AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan.
J Infect Chemother ; 28(9): 1340-1343, 2022 Sep.
Article em En | MEDLINE | ID: mdl-35644734
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans País/Região como assunto: Asia Idioma: En Revista: J Infect Chemother Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans País/Região como assunto: Asia Idioma: En Revista: J Infect Chemother Ano de publicação: 2022 Tipo de documento: Article